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Abstract
To clarify the role of α-synuclein (αSyn) in neuronal membrane remodeling, we analyzed the expression of αSyn
in neurons with a dysfunction of PLA2G6, which is indispensable for membrane remodeling. αSyn/phosphorylated-αSyn
(PαSyn) distribution and neurodegeneration were quantitatively estimated in PLA2G6-knockout (KO) mice, which
demonstrate marked mitochondrial membrane degeneration. We also assessed the relationship between αSyn
deposits and mitochondria in brain tissue from patients with PLA2G6-associated neurodegeneration (PLAN) and
Parkinson’s disease (PD), and quantitatively examined Lewy bodies (LBs) and neurons. The expression level of
αSyn was elevated in PLA2G6-knockdown cells and KO mouse neurons. Strong PαSyn expression was observed in
neuronal granules in KO mice before onset of motor symptoms. The granules were mitochondrial outer membrane
protein (TOM20)-positive. Ultramicroscopy revealed that PαSyn-positive granules were localized to mitochondria with
degenerated inner membranes. After symptom onset, TOM20-positive granules were frequently found in ubiquitinated
spheroids, where PαSyn expression was low. Axons were atrophic, but the neuronal loss was not evident in KO mice. In
PLAN neurons, small PαSyn-positive inclusions with a TOM20-positive edge were frequently observed and clustered into
LBs. The surfaces of most LBs were TOM20-positive in PLAN and TOM20-negative in PD brains. The high proportion of
LB-bearing neurons and the preserved neuronal number in PLAN suggested long-term survival of LB-bearing neurons.
Elevated expression of αSyn/PαSyn in mitochondria appears to be the early response to PLA2G6-deficiency in neurons.
The strong affinity of αSyn for damaged mitochondrial membranes may promote membrane stabilization of
mitochondria and neuronal survival in neurons.
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Introduction
It is well known that α-synuclein (αSyn) is a pathological
marker of Parkinson disease (PD), because αSyn/phos-
phorylated αSyn (PαSyn) is a main component of Lewy
bodies (LBs). The physiological function of αSyn has
recently become known. As a pre-synaptic chaperone,
αSyn promotes soluble NSF-attachment protein receptor
(SNARE)-complex assembly [9, 22]. αSyn also localizes to
nuclei and subcellular organelles, including mitochondria
and mitochondrion-associated endoplasmic reticulum
(ER) membranes [5, 16, 37]. αSyn binds to lipid mem-
branes [42, 43], in particular, to membranes with high
curvature, such as synaptic vesicles and mitochondrial
inner membranes [5, 25, 52]. The N-terminus of αSyn lies
along the surface of the membrane [5, 43], where it senses
lipid-packing defects and leads to membrane remodeling
and stabilization [7, 29].
Mitochondria comprise an inner and an outer mem-
brane that separate the intermembrane space and the
matrix. Mitochondria have various functions, including
oxidative phosphorylation, lipid metabolism, endocytosis
[24], apoptosis, and calcium and iron homeostasis [32].
A mitochondrial inner membrane-specific phospholipid,
cardiolipin, is crucial for the integrity and function of
mitochondria [25, 32]. In the brains of mice lacking
αSyn, the mitochondrial lipid composition changes, and
complex I/III activity is reduced [12]. Moreover, the N-
terminus of αSyn regulates mitochondrial membrane
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permeability [40]. Together, these findings suggest that
αSyn is integral to maintaining mitochondrial function.
Calcium-independent phospholipase A2β, encoded by
PLA2G6, has diverse functions, such as releasing lipid me-
diators, inflammation, vascular relaxation, and secretion, by
hydrolyzing the sn-2 ester bond in phospholipids [8, 10, 27,
28, 51]. In PLA2G6-associated neurodegeneration (PLAN)
[19, 26], formerly called Seitelberger disease, a variety of
neurological deficits are present from infancy, suggesting
the importance of PLA2G6 in the brain. PLAN encom-
passes a number of phenotypes, such as infantile neuroaxo-
nal dystrophy and adult-onset dystonia-parkinsonism
(Park14). Although these phenotypes differ in the degree
and distribution of neurodegeneration, αSyn/Lewy-related
pathology is commonly observed [15, 31, 36].
The pathogenesis of PLA2G6 deficiency is thought to
involve dysfunction of mitochondria and membrane re-
modeling [13, 20]. Pla2g6-knockout (KO) mice show slow
progression of motor deficits, and there is a progressive
formation of spheroids and tubulovesicular structures
[23, 41], similar to that seen in PLAN [11, 17]. Recently,
we reported that the spinal cord neurons in Pla2g6-KO
mice have ultra-microscopically abnormal mitochondria,
with degenerated inner membranes, which are periodic acid
Schiff (PAS)-positive, negative for an inner membrane pro-
tein (cytochrome c oxidase, CCO), and positive for an outer
membrane protein (translocase of the outer mitochondrial
membrane, TOM20) on immunohistochemistry [4, 45]. In
mass spectrometry, the content of mitochondria-specific
phospholipid, cardiolipin, is high in Pla2g6-KO mice. These
findings suggest dysregulation of phospholipid metabolism
in the mitochondrial inner membrane. We also previously
demonstrated low expression of CCO and low production
of ATP in PLA2G6-knockdown cells, suggesting mitochon-
drial dysfunction [3].
Genetic mutation of SNCA [34] and multiple copies of
SNCA [38] cause PD, suggesting the toxic function due to a
genetic abnormality of αSyn [5, 48]. On the other hand, in
the brains of elderly people without neuropsychiatric symp-
toms, where widespread αSyn/Lewy-related pathology is
seen [39], the severity of αSyn/Lewy-related pathology is
not associated with the clinical course in PD [14, 18]. In
spite of many intensive researches [1, 5, 14, 18, 35, 48], the
biological significance of LBs in sporadic PD and other fa-
milial PD is not yet fully understood. In this study, we
aimed to clarify the reason for αSyn accumulation in neu-
rons, and pathologically analyzed the relationship between
αSyn and mitochondrial membranes in PLAN and in
Pla2g6-KO mice.
Materials and methods
Generation of Pla2g6-Kd cells
We generated PLA2G6 gene knockdown (Kd) SH-SY5Y
human neuroblastoma cells, as described before [3].
Briefly, SH-SY5Y neuroblastoma cell line was obtained
from American Tissue Culture Collection (ATCC, Ma-
nassas, VA). Cells were grown in Dulbecco’s modified
Eagle’s medium high glucose (high-glucose formulation,
Nacalai Tesque, Kyoto, Japan) supplemented with 10 %
fetal bovine serum, 100 units/ml penicillin, and 100 μg/
ml streptomycin. Cell cultures were all kept at 37 °C.
The small interfering RNA (siRNA) targeting human
PLA2G6 gene (Life technologies, Carlsbad, CA) and
negative control siRNA (Qiagen, Hilden, Germany), were
obtained. Subconfluent SH-SY5Y cells were transfected
with siRNAs using Lipofectamine RNAiMax (Invitrogen,
Carlsbad, CA). The targeting sense sequence for human
PLA2G6 in SH-SY5Y cells is 5′-GACCAAAGAGCAAG
UGACAAAUGUU-3′.
RNA expression analysis
The absence of the PLA2G6 expression was confirmed in
Pla2g6-Kd cells, as described before [3]. Briefly, total RNA
was extracted from siRNA-transfected SH-SY5Y cells using
the RNeasy Kit (Qiagen, Hilden, Germany), and the RNA
concentrations were determined spectrophotometrically.
cDNA was generated using the SuperScript VILO cDNA
Synthesis Kit (Invitrogen, Carlsbad, CA) from 100 ng of
each RNA sample. RT-PCR was used to confirm reduced
expression levels of PLA2G6 gene (data not shown).
Western blotting
Cells were collected after transfection for 48 h. Samples
(n = 6 per group) were prepared as described before [3].
Cells, which were transfected with negative control
siRNA, were used as control. The protein (10 μg) was
separated on 15 % SDS-PAGE, electrotransferred to a
polyvinylidene difluoride (PVDF) membrane (Bio-Rad,
CA, USA), blocked with 5 % nonfat milk and incubated
overnight at 4 °C with the primary antibody against
GAPDH (1:1000, Millipore) and α synuclein (αSyn,
1:200, IBL, Fujioka, Japan). The bands were visualized
with enhanced chemiluminescence’s reagents and ex-
posed to X-ray film.
Immunocytochemistry
Cells were fixed in 4 % paraformaldehyde for 30 min.
After washing with PBS three times, cells were perme-
abilized with 0.2 % Triton X-100 for 30 min, and incu-
bated with 10 % skim milk in PBS for 60 min. The
antibodies against 20-kDa translocase of the outer
mitochondrial membrane (1:100 dilution, TOM20, im-
port receptor, expressed on the mitochondrial outer
membrane; Santa Cruz, Dallas, TX) and αSyn (1:100
dilution, LB509, Abcam, Cambridge, England) were
used as primary antibodies. Alexa Fluor1488 goat anti-
rabbit IgG (H + L) antibody (Life Technologies) and
Alexa Fluor1568 goat anti-mouse IgG (H + L) antibody
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(Life Technologies) were used as the secondary antibodies.
Confocal laser-scanned images were obtained using an
LSM 510 META (Carl Zeiss, Oberkochen, Germany).
Animals
All animals were handled in accordance with the Guide-
lines for Animal Experimentation of Osaka University
(No.26-044-000).
Mice carried a homozygous disruption of Pla2g6 on a
C57BL/6 background [41], aged 15 weeks (n = 3, pre-
clinical stage, 1 male and 2 females); 1 year (n = 4, early
symptomatic stage, 1 male and 3 females); and 2 years
(n = 5, end stage, 2 males and 3 females); and wild-type
mice, aged 15 weeks (n = 3, 1 male and 2 females); and
2 years (n = 4, 1 male and 3 females) were obtained.
After perfusion of 4 % paraformaldehyde, spinal cords
were removed and immersed in the same fixative overnight
at 4 °C, after which 4-μm–thick paraffin sections were pre-
pared. Sciatic nerves were also obtained. The sciatic nerves
and small pieces of the spinal cord were fixed with 2.5 %
glutaraldehyde and processed to epon blocks, as described
previously [44]. Epon sections (1-μm–thick) were stained
with thionine and PAS.
Autopsy
The research presented in this study has been approved
by the University Ethics Committee Osaka University
Graduate School of Medicine (No. 10038). Consent for
autopsies were obtained from legal representatives for all
subjects in accordance with local institutional review
board requirements, which was approved by the University
Ethics Committee (Osaka University Graduate School of
Medicine, Osaka, Japan).
Autopsy samples of one PLAN case (age at death:
20 years; disease duration: 17 years), seven Parkinson’s
disease cases (age at death: 73 ± 9 years; disease dur-
ation: 13 ± 8 years), and five non-neurodegenerative
control cases (age at death: 61 ± 16 years) were ob-
tained. Paraffin-embedded 6-μm–thick sections of the
midbrain, at the level of the red nucleus, upper pons,
and upper medulla, were prepared and examined, be-
cause of the high frequency of LBs in those area in both
PLAN [15, 31, 36] and PD.
Immunohistochemistry
Deparaffinized sections were incubated for 30 min with
0.3 % H2O2 to quench endogenous peroxidase activity,
and were then washed with phosphate-buffered saline
(PBS). The primary antibodies used were rabbit poly-
clonal antibodies against α-Syn (1:2000 dilution for
mouse, 1:5000 dilution for human; Sigma −Aldrich, St.
Louis, MO), TOM20 (1:40 dilution for mouse, 1:100 di-
lution for human, Santa Cruz), cathepsin D (lysosomal
enzyme, 1:400 dilution, Dako, Glostrup, Denmark),
ubiquitin (1:2000 dilution, DAKO), and mouse mono-
clonal antibodies against PαSyn (specific for Ser129-
phosphortlated αSyn, 1:800 dilution for mouse, 1:2000
dilution for human, pSyn#64; Wako, Osaka, Japan) and
cytochrome c oxidase subunit IV (CCO, respiratory
complex IV, expressed on the mitochondrial inner
membrane; 1:300 dilution for mouse, 1: 1000 dilution
for human; Invitrogen) and KDEL (Lys-Asp-Glu-Leu,
1:500 dilution, Enzo Life Sciences, Farmingdale, NY).
Goat anti-rabbit and anti-mouse immunoglobulins con-
jugated to peroxidase-labeled dextran polymer (Dako
Envision+, Dako) were used as secondary antibodies.
Reaction products were visualized with 3,3′-diamino-
benzidine tetrahydrochloride (Vector Laboratories,
Burlingame, CA), and hematoxylin was used to coun-
terstain the cell nuclei. The immunostaining patterns
were compared in serial sections. Some sections were
additionally stained with Luxol Fast Blue (LFB) or PAS.
Double immunohistochemistry
For double immunohistochemistry, two primary anti-
bodies were combined, including antibodies for αSyn
(αSyn or PαSyn), mitochondrial membrane markers (CCO
or TOM20), ubiquitin, and tyrosine hydroxylase (TH).
The VECTASTAIN ABC-AP kit (Vector Laboratories)
and ALKALINE PHOSPHATASE SUBSTRATE KIT IV
BCIP/NBT (Vector Laboratories) were used for the
secondary antibody and visualization of reaction products,
respectively.
Quantitative pathological analysis of anterior horn cells
and sciatic nerves of mice
We estimated the number of neurons filled with PαSyn-
positive granules and the number of motor neurons in
the anterior part of mouse cervical spinal cord and mye-
linated fibers in sciatic nerves. The neurons with clear
nucleoli and cell bodies with a diameter greater than
25 μm, presumed to be alpha motor neurons, were
counted [44]. To this end, video images were obtained
for each 4-μm–thick Nissl-stained paraffin section and
each 1-μm–thick toluidine blue-stained epon section,
using a digital camera (KEYENCE VB-7010, KEYENCE,
Osaka, Japan) attached to a light microscope (ECLIP-
SEE800, Nikon, Tokyo, Japan). The diameters of moto-
neurons showing clear nucleoli and cell bodies, and the
myelinated fibers in the sciatic nerves were measured
using image analysis software (VH-H1A5, KEYENCE).
Four sections of cervical cords were examined for each
mouse. For the sciatic nerves, three fields (100× magnifi-
cation) per mouse were examined. The number of moto-
neurons, large myelinated fibers (diameter, >10 μm), and
total myelinated fibers in wild-type mice (2-years-old)
and Pla2g6-KO mice (1-year-old and 2-years-old) was
counted. The density of myelinated fibers (per mm2) was
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calculated for each mouse. The differences in the num-
ber of motoneurons and the fiber density between
wild-type mice and Pla2g6-KO mice were statistically
analyzed using the Wilcoxon rank sum test.
Ultrastructural analysis
Ultrathin sections of the spinal cord from Pla2G6-KO
mice aged 15 weeks, 56 weeks, or 100 weeks were pre-
pared and stained with uranyl acetate and lead citrate,
and examined using a transmission electron microscope
(H-7650; Hitachi High-Technologies Co., Tokyo, Japan).
Quantitative pathological analysis of TOM20-expression
on the surface of human LBs
Double immunohistochemistry was performed for PαSyn
(in brown) and for TOM20 (in blue) in the substantia
nigra, in the locus coeruleus, or in the dorsal motor
nuclei of the vagus nerve. Neuronal round or spherical
PαSyn-positive inclusions with a clear contour were de-
fined as LBs. In double immunohistochemistry, PαSyn-
positive LBs (brown) were separated into three types,
according to the expression pattern of TOM20 (blue) on
the surface: TOM20-negative, partially TOM20-positive,
and completely TOM20-positive (Fig. 7). Where less
than half of the LB surface was positive for TOM20, the
LB was classified as “partially TOM20-positive” and
where more than half of the LB surface was positive for
TOM20, the LB was classified as “completely TOM20-
positive”. We counted the number of each type of LB in
the substantia nigra, the locus coeruleus, and dorsal
motor nuclei of the vagus in each patient. Slides were
examined with a × 40 objective, and the microscope im-
ages were viewed on video-screen. The contours of the
substantia nigra and the locus coeruleus, and dorsal
motor nuclei of the vagus were drawn on the slide. The
number of LBs with various surface expression levels of
TOM20 was compared between PLAN and PD sections.
Estimation of dopaminergic neuron density and the
proportion of LB-bearing neurons in controls and PD and
PLAN patients
Double immunohistochemistry was performed against
PαSyn (brown) and TH (blue) in human brainstem sec-
tions. In double immunohistochemistry, we counted the
number of TH-positive (dopaminergic) neurons bearing
LBs and total TH-positive neurons in the substantia
nigra and the locus coeruleus [47]. Slides were examined
with a × 40 objective, and the microscope image was
viewed on a video-screen. The contours of the substantia
nigra and the locus coeruleus were drawn on the slide.
The neuron density over three fields was calculated for
each patient. The density (per mm2) of TH-positive
neurons bearing LBs and total TH-positive neurons
were compared between PLAN, PD (n = 7), and control
(n = 5) individuals.
Estimation of the influence of LBs on TH expression levels
in dopaminergic neurons
Double immunohistochemistry was performed for PαSyn
(brown) and TH (blue). The immunostaining of TH was
compared between dopaminergic neurons with LBs and
those without LBs, in the substantia nigra and locus
coeruleus. The brainstem was compared between PLAN
and PD (n = 7) individuals.
Fig. 1 Elevated expression of αSyn in Pla2g6-knockdown (Kd)
SH-SY5Y cells. Western blotting analysis (upper panel) and the
immunocytochemistry (lower panel). Normalizing by GAPDH, the
expression level of a-syn in PLA2G6 Kd cells was estimated (n = 6
per group). Each bar represents the mean ± SD. *p < 0.05. Mitochondria
or nucleus was visualized by a-Tom20 antibody and Hoechst33342
staining, respectively. Scale bar represents 10 μm
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Statistical analysis
All statistical analyses of histopathological data in mice
were performed using SPSS Statistics software for Win-
dows version 20.0 (SPSS, Chicago, IL). Data are
expressed as the mean (SD). Mann–Whitney U test was
used to analyze the ratio of αSyn/GADPH in cultured
cells, the number of neurons and the density of large
myelinated fibers and total myelinated fibers in mice. P







Fig. 2 Prominent accumulation ofαSyn/phosphorylated αSyn (PαSyn) in the spinal cord of Pla2g6-knockout (KO) mice at the preclinical-stage. a, f wild-
type mice; b-d, g-m, Pla2g6-KO mice at 15 weeks; e, Pla2g6-KO mice at 2 years; a-n, Anterior part of spinal cords; a-c, e, Immunohistochemistry for αSyn; d,
Immunohistochemistry for αSyn plus Periodic Acid Shiff (PAS); f-n, Immunohistochemistry against PαSyn (f-h, j), CCO (i), and TOM20 (k), and cathepsin D
(n), Immunohistochemistry for PαSyn (l) or KDEL (m) plus PAS, respectively; Scale bar represents 80 μm in (a, b, f, g), and 20 μm in (c-e, h-n). The graph
shows the number of neurons filled with PαSyn-positive granules in wild-type mice at 2 years of and Pla2g6-KO mice at 15 weeks, 1 year, and 2 years of
age. a The gray matter of the control spinal cord is moderately stained, showing a punctate pattern; b, c αSyn expression is highly diffuse in the gray
matter of young Pla2g6-KO mice. The neuron is mildly positive for αSyn (arrow in c), which is filled with PAS-positive granules, as shown in a serial section
(d). e In the gray matter of KO mice at end stage, several vacuoles and spheroids are seen, which are negative for αSyn (*). f No staining is seen in the
control. (g) In KO mice at the pre-clinical stage, there are many tiny PαSyn-positive granules in the anterior horn cells (arrows) and the proximal axons
(white arrowheads). h, i, PαSyn-positive small granules (arrows in h) are virtually negative for CCO (arrows in i) in the same neurons as in the serial section.
j, k Very small PαSyn-positive granules (arrows in j) are prominently observed in the same neurons filled with TOM20-positive granules (arrows in k) in the
serial section. l,m, PAS-positive granules are PαSyn-positive (l, arrows) and KDEL-negative (m, arrows). n A swollen neuron is negative for cathepsin
D (arrow)
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Results
Cultured cells
High expression of αSyn in Pla2g6-knockdown cells
To clarify the relationship between αSyn and PLA2G6
dysfunction in cultured neurons, we analyzed the ex-
pression level of αSyn in Pla2g6-Kd SH-SY5Y human
neuroblastoma cells. In the western blotting analysis of
Pla2g6-Kd cells, αSyn expression was strikingly high
(Fig. 1). The difference between Kd cells and negative
control cells was significant (n = 6 per group, p < 0.05).
Colocalization of αSyn and translocator of outer mito-
chondrial membrane 20 (TOM20) was demonstrated by
immunocytochemistry.
Mice
Strong expression of αSyn in the spinal cord of Pla2g6-KO
mice at the preclinical-stage
To clarify the relationship between αSyn and PLA2G6
dysfunction in mice in vivo, we analyzed the distribution
of αSyn in Pla2g6-KO mice using immunohistochemis-
try. In wild-type mice of both 15 weeks and 2 years of
age, the neuropil was moderately stained for αSyn, with
punctate pattern (Fig. 2a). In Pla2g6-KO mice at the
pre-clinical stage (15 weeks), the immunoreactivity of
αSyn was highly diffuse in the gray matter (Fig. 2b).
αSyn staining in the neuropil had a punctate pattern,
similar to that in wild-type mice, but the cytoplasm of
some swollen neurons was also mildly positive for αSyn
(Fig. 2c). PAS staining showed that αSyn-positive swollen
neurons were filled with PAS-positive granules (Fig. 2d).
With age, large vacuoles and spheroids in the neuropil
were increased in number, where the expression level of
αSyn was almost none or low (Fig. 2e).
Strong expression of PαSyn in CCO-negative, TOM20-
positive granules in young Pla2g6-KO mice
To determine if there was a relationship between sub-
cellular micro-organelle localization and accumulation
of PαSyn, the most important modified-form of αSyn
after transcription, we compared the distribution of
PαSyn with markers of subcellular micro-organelles in
neurons of Pla2g6-KO mice. Immunohistochemistry
with an antibody specifically directed against Ser129-
phosphorylated αSyn (pSyn#64) revealed the absence of
PαSyn in the wild-type mice (Fig. 2f ). In Pla2g6-KO
mice at 15 weeks, very small PαSyn-positive granules
were prominent in the cytoplasm and proximal axons
of anterior horn cells (Fig. 2g, h, j) and dorsal root gan-
glion cells (data not shown). In some of the swollen
neurons filled with small PαSyn-positive granules, the
nuclei were atrophic (Fig. 2h, j). By comparing serial
sections, we found that the neurons filled with PαSyn-
positive granules were CCO-negative (Fig. 2i) and
TOM20-positive (Fig. 2k). The granules were PAS-
positive (Fig. 2l), KDEL-negative (Fig. 2m), and cathep-
sin D-negative (Fig. 2n). The number of neurons filled
with PαSyn-positive granules is shown in the graph
(Fig. 2) and Table 1.
Morphological changes of PαSyn-positive granules in
Pla2g6-KO mice with age
To assess the relationships between high PαSyn expres-
sion and neurodegeneration in Pla2g6-KO mice, we ana-
lyzed the age-dependent distribution of PαSyn. In
Pla2g6-KO mice at 15 weeks, very small PαSyn-positive
granules were prominently observed in the proximal
axons (Fig. 3a) and cytoplasm of anterior horn cells. At
the early symptomatic stage (1 year), there were only a
few PαSyn-positive granules in neuronal cytoplasm.
Swollen neurons, filled with PαSyn-positive granules,
were completely absent (Table 1). In the proximal axons,
there were many PαSyn-positive granules, some of which
were large and deformed (Fig. 3b). Double immunohis-
tochemistry revealed PαSyn co-localization with TOM20
in the granules (Fig. 3c).
At the end stage (2 years), some of the PαSyn-positive
granules showed degenerated membranes (Fig. 3d, e).
Using double immunohistochemistry, PαSyn was shown
to co-localize with TOM20 in the granules and the
degenerated membrane of the granules (Fig. 3f ).
Table 1 The time course of Pα-syn expression in neurons and the number of motor neurons and myelinated fibers of Pla2g6-knockout
(KO) mice
Wt KO
2y (n = 4) 15w (n = 3) 1y (n = 4) 2y (n = 5)
Number of neurons filled
with PαSyn (+) granules
0 12 (10) 0 0
Number of AHCs 44 (6) n.e. 44 (2) 33 (10)
Sciatic nerve (distal axon) Density of myelinated fibers 17567 (1513) n.e. 14281 (2086) 18850 (1745)
Sciatic nerve (distal axon) Density of large myelinated fibers 1623 (314) n.e. 613 (172) 156* (104)
PαSyn phosphorylated α-synuclein, Wt wild-type, KO Pla2g6-knockout, 15 w 15 weeks, 1 y 1 year, 2y 2 years, AHC anterior horn cell, number of anterior horn cells
mean (SD), n.e. not examined, Density of myelinated fibers number of myelinated fibers per mm2, large myelinated fibers myelinated fibers with a diameter larger
than 10 μm, *p <0.05
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Semi-thin and ultra-microscopic image of small PαSyn-
positive granules in Pla2g6-KO mice
To define the structure of small PαSyn-positive granules
in Pla2g6-KO mouse neurons, we compared the the
structures observed on semi-thin or ultra-microscopic
pictures with the small PαSyn-positive granules seen on
paraffin sections. In thionine-stained semi-thin sections,
we observed dark colored granules in the cytoplasm and
proximal axons of neurons in young KO mice (Fig. 3g).
The granules were clearly PAS-positive (Fig. 3h), and
showed a similar size and distribution as PαSyn-positive
granules. Ultra-microscopically, round mitochondria could
be seen in which the cristae were partially replaced by
small dense granules both in the perinuclear space of
a b c
d e f
g h i j
k l m
Fig. 3 Age-dependent morphological changes in PαSyn-positive mitochondria in axons. a-f paraffin section; g, h epon semi-thin section; i-m
ultramicroscopy; a, g-j Pla2g6-KO mouse at 15 weeks; (b, c) Pla2g6-KO mice at 1 year; d-f, k-m, Pla2g6-KO mice at the 2 years. a, b, e, g, h, j, l, m
Anterior column of the spinal cord; c, f anterior root; d, i, k perinuclear of neuron; a, b, d, e Immunohistochemistry for PαSyn; c, f double
immunohistochemistry for PαSyn (blue) and TOM20 (brown); g thionine staining; h PAS staining. Scale bars represent 40 μm in (a, b, e), 10 μm
in (c, d, g, h), 5 μm in (f), 500 nm in (i and k), and 1 μm in (j, l, m). a At preclinical-stage, small PαSyn-positive granules (arrows) could be seen
in axons. b At early symptomatic stage, the PαSyn-positive granules became large and irregular-shaped (arrows). c Co-localization of PαSyn
and TOM20 is evident (arrows) in the granules. d At end stage, PαSyn-positive granules and membranes (arrow) are seen in neurons and in
the neuropil. e PαSyn-positive membranous structures (arrows) coincide with the small PαSyn-positive granules. f The membranous structures
and granules that are positive for PαSyn and TOM20 combine into a complex (arrows). g, h In the axons, there are many dark-colored granules
(arrows in g), which are clearly stained by PAS (arrow in h). i In the perinuclear space of swollen neuron filled with granules, mitochondrion with partly
degenerated crista (arrowhead) and numerous round bodies filled with dense granules. j In a myelinated axon, many spherical mitochondria and round
bodies filled with dense granules are seen. The structure of the axon is virtually normal. k In the mitochondrion (arrowhead) around the nuclei
of neurons, most of the cristae are replaced by dense granules. l Many mitochondria with tubular and vesicular cristae (arrowheads) cluster in
the axon.m Membranous degeneration, tubulovesicular structures (black arrowhead) and abnormal mitochondria (arrowhead) can be seen together in
the spheroid
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neurons (Fig. 3i) and in axons (Fig. 3j). These abnormal
mitochondria and round bodies were of a similar size and
had a similar distribution as the PAS-positive granules in
semi-thin sections, suggesting that PAS-positive granules
were indicative of PαSyn-loading abnormal mitochondria.
In the aged KO mice, fewer round mitochondria could
be seen in which the cristae were partially replaced by
small dense granules in the perinuclear space of neurons
(Fig. 3k). In the axons, mitochondria with branching and
tubular cristae were frequently seen, and were clustered
together (Fig. 3l). In the spheroid, highly degenerated
mitochondria, tubulovesicular structures and degener-
ated membranes were combined to form an irregular
structure (Fig. 3m), suggesting severe degeneration of
mitochondrial membranes.
Different distribution of ubiquitin and PαSyn in Pla2g6-
KO mice
To determine whether the ubiquitin-proteasome system is
activated in PαSyn-loading mitochondria, we estimated
the relationship between ubiquitin and mitochondrial
membrane protein by double immunohistochemistry. At
the pre-clinical stage, there were rare ubiquitin deposits in
the spinal cord of Pla2g6-KO mice (Fig. 4a-c). At the early
symptomatic stage (1-year-old), ubiquitin-positive struc-
tures were frequently observed in the neuropil and the
axons (Fig. 4d), but not in the neuronal cytoplasm. Double
immunohistochemistry revealed that the distribution of
PαSyn and ubiquitin in the axons was markedly different
(Fig. 4e). At the end stage (2-year-old), ubiquitination be-
came severe in axons, but no ubiquitination was observed
a b
c d e
f g h i
Fig. 4 Ubiquitination of mitochondrial membranes at later stages. a-c Pla2g6-KO mouse (15 w); d, e Pla2g6-KO mouse (1 year); f-i Pla2g6-KO
mouse (2 years); a, b, g anterior part of the spinal cord; c-f anterior root; h, i posterior part of the spinal cord; a, c immunohistochemistry for
ubiquitin; b, d, f immunohistochemistry for ubiquitin plus LFB staining; e, g double immunohistochemistry for PαSyn (brown) and ubiquitin
(blue); h, i double immunohistochemistry for ubiquitin (brown) and TOM20 (blue); Scale bars represent 80 μm in (a), 20 μm in (b-g) and 10 μm
in (h, i). a At the pre-clinical stage, there is almost no expression of ubiquitin. b The anterior horn cell (arrow), filled with small granules, is negative for
ubiquitin. c In the anterior root, no ubiquitin-positive axon can be observed. d At the early symptomatic stage, ubiquitin-positive axons (arrows) with
LFB-positive (blue) myelin are seen in the anterior root. e The distribution of small PαSyn-positive granules (brown, arrows) and ubiquitin (blue) are
different. f Ubiquitin-positive axons (arrows) are shown. Most of the myelinated fibers have become atrophic. g The distribution of small PαSyn-positive
granules (brown) and ubiquitin (blue) differs. h In the center of a large spheroid, TOM20-positive (blue) granules are ubiquitin-positive (brown, arrow).
i In the markedly ubiquitinated spheroid (brown), the expression of TOM20 (blue) is still observed
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in the cytoplasm (data not shown). Double immunohisto-
chemistry showed almost no colocalization of PαSyn and
ubiquitin (Fig. 4g) but showed frequent colocalization of
TOM20 and ubiquitin in the spheroids (Fig. 4h, i).
Significant decrease in the density of large myelinated
fibers, but not neuron number, in the spinal cord
To clarify the degree of neurodegeneration in axons and
neurons that contained PαSyn-positive granules, from
young mice, we estimated the number of axons and neu-
rons in Pla2g6-KO mice after symptom onset. Axonal
degeneration progressed as reported previously [41] and
myelinated fibers became atrophic with age. Quantitative
analysis (Table 1) revealed a significant decrease in large
myelinated fibers (>10 μm in diameter) with age (KO
mice 1y, n = 4, p =0.057; KO mice 2 y, n = 5, p <0.05).
The density of the total myelinated fibers in Pla2g6-KO
mice after onset was similar to that in the wild-type
mice. The number of anterior horn cells in Pla2g6-KO
mice at the early symptomatic stage was similar to that
of wild-type mice. Even at the end stage, the number of
neurons was not significantly different between Pla2g6-
KO and wild-type mice (p = 0.067).
Human
Prominent formation of Lewy Bodies (LBs) in a PLAN
patient with a mutation in PLA2G6
In the midbrain, upper pons, and upper medulla of
both PD and PLAN patients, numerous neuronal in-
clusions that were positive for αSyn and PαSyn
(pSyn#64) could be seen. The affected areas included
the substantia nigra, dorsal raphe nucleus, locus
coeruleus, dorsal motor nuclei of the vagus nerve,
and the reticular formation. Morphologically, the in-
clusions were round or spherical, similar to Pale
bodies or LBs seen in PD (Fig. 5a). In PD, most of
the PαSyn-positive LBs were present in the neuropil,
particularly in the region showing severe neuronal
loss. In the brain of the PLAN patient, LBs were ob-




Fig. 5 Prominent formation of Lewy bodies in PLAN. a Parkinson’s disease (PD) case; b-f PLA2G6-associated neurodegeneration (PLAN) case;
a, b Dorsal motor nuclei of vagus (nX); c, d Locus coeruleus (LC); e, f Substantia nigra (SN); a-c, e Immunohistochemistry for PαSyn plus PAS
staining; d, f Double immunohistochemistry for PαSyn (brown) and tyrosine hydroxylase (TH, blue). Scale bars represent 40 μm in (a-c, e),
and 20 μm in (d, f). a In PD, PαSyn-positive inclusions, Lewy bodies (arrows) are observed mainly in the neuropil. b In PLAN, there are
many Lewy neurites and Lewy bodies (LBs, arrows) both in the neurons and in the neuropil. c Cytoplasmic LBs are indicated with arrows. d Spherical
Lewy neurites in the center of this panel and a LB in TH-positive neuron (arrow) are shown. e The neurons in the locus coeruleus are well preserved
despite prominent LBs (arrows). f The LBs in TH-positive neurons are small, but have the apparent core and halo structure (arrows)






Fig. 6 The relationship between the distribution of αSyn or PαSyn and mitochondrial membrane proteins. Upper panels, Parkinson’s disease
(PD); a-e Dorsal motor nuclei of the vagus; f Locus coeruleus; a-c Double immunohistochemistry for αSyn (blue) and CCO (brown); d, e
Double immunohistochemistry for PαSyn (brown) and TOM20 (blue); f Double immunohistochemistry for αSyn (blue) and TOM20 (brown).
Lower panels, PLA2G6-associated neurodegeneration (PLAN); a-d Dorsal motor nuclei of vagus; e-h Locus coeruleus; i Substantia nigra; a-c
Double immunohistochemistry for αSyn (blue) and CCO (brown); d, i Double immunohistochemistry for αSyn (blue) and TOM20 (brown); e-h Double
immunohistochemistry for PαSyn (brown) and TOM20 (blue). Scale bar represents 8 μm in the upper panel and (a-f) in the lower panel (a-i). Upper
panel, Parkinson’s disease (PD). a There is an amorphous deposit of αSyn (arrow) in the CCO-positive cytoplasm. b In the center of the αSyn-positive LB
(arrow), the expression of CCO is negative. c The sausage-like Lewy body (LB) has a small rim, which is CCO-positive (arrow). d There are a few PαSyn-
positive granules (arrow) that are mildly TOM20-positive on the surface. e The neuron is filled with sausage-like LBs arrows, which are almost negative
for TOM20. f In the neuron, the surface of the LB is mildly positive for TOM20. Lower panel, PLA2G6-associated neurodegeneration (PLAN) a There are
some CCO-positive dots around the irregular αSyn-positive deposit (arrow). b αSyn-positive inclusion (arrow) contains some CCO-positive
granules. c CCO expression is seen in only a part of the surface (arrows) of αSyn-positive LB. d Under the αSyn deposit, there are clear TOM20-
positive dots (arrow) in the cytoplasm. e In the neuronal cytoplasm, there are several PαSyn-positive granules (arrow), on which the surface is
completely TOM20-positive. f PαSyn-positive granules are clustered to form a thin inclusion (arrow), on which the surface is positive for TOM20. g PαSyn-
positive granules with TOM20-positive rim are clustered to form one round inclusion (arrow). h In the core of the LB, the immunoreaction of PαSyn and
TOM20 are absent. In the halo of LB (arrow), PαSyn-positive granules with a TOM20-positive rim make a line. i PαSyn and TOM20-positive membrane-like
structure covers the surface of LB (arrow)
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(Fig. 5b-f ). The size of LBs in PLAN varied, as it does
in PD.
PαSyn -positive small inclusions colocalized with the
mitochondrial membrane protein in PLAN
To assess the relationship between αSyn/PαSyn de-
posits and mitochondria, we analyzed the neurons
affected in PD and in PLAN using a double immuno-
histochemical assay. Double immunohistochemistry
revealed amorphous deposits of αSyn in the CCO-
and TOM20-positive cytoplasm of neurons both in
PD and in PLAN patients (PD; Fig. 6a, PLAN;
Fig. 6d). As more αSyn accumulated in the neuronal
cytoplasm, the CCO-immunoreactivity diminished (PD:
Fig. 6b, c, PLAN: Fig. 6a-c). In PLAN neurons, small
PαSyn-positive inclusions with a TOM20-positive edge
were frequently found, but similar inclusions were rare in
PD (PD: Fig. 6d-f, PLAN: Fig. 6e).
Clustering of PαSyn-positive small inclusions to form a
larger neuronal inclusion in PLAN
To clarify the relationship between PαSyn-positive
small inclusions and LBs, we analyzed the distribution
of PαSyn-positive small inclusions in neurons affected
in PLAN. In PLAN neurons, small PαSyn-positive in-
clusions with a TOM20-positive edge appeared to
cluster, and formed a larger narrow (PLAN: Fig. 6f )
or round (PLAN: Fig. 6g) inclusion. In some LBs,
small PαSyn-positive inclusions with a TOM20-
positive edge appeared to cover the surface (PLAN:
Fig. 6h), whereas the immunoreactivity of PαSyn was
reduced in the center. PαSyn and TOM20-positive
membranous structures also appeared to cover the
surface of LBs (Fig. 6i).
Quantitative analysis of LBs with TOM20 present on their
surface
To evaluate the relationship between LBs and mitochon-
dria quantitatively, we counted the number of LBs with
mitochondrial membrane protein (TOM20) present on
their surface in PD and in PLAN. The number of LBs in
each area is shown in Fig. 7. In all three investigated
areas of the PD brains, most LBs were TOM20-negative
on the surface. In the PLAN brain, most LBs were
TOM20-positive on the surface. In all three investigated
areas of the PLAN brain, more than half of the LBs were
completely TOM20-positive. The surfaces of most LBs
were TOM20-positive in PLAN and TOM20-negative in
PD brains.
Proportion of LB-bearing dopaminergic neurons and
neuronal density
To assess the survival rates of LB-bearing dopaminergic
neurons, we estimated the neuronal density and the pro-
portion of LB-harboring neurons in both PD and PLAN.
The density of LB-bearing TH-positive neurons and total
number of TH-positive neurons in substantia nigra and
locus coeruleus are shown in Table 2. In the PD brains,
the density of LB-bearing TH-positive neurons was low,
because most LBs were found in the neuropil; this density
was 1 ± 1 (mean ± S.D.) in the substantia nigra and 2 ± 2
in the locus coeruleus (number per 1 mm2). In the PLAN
brain, the density of LB-bearing neurons was 6 in the sub-
stantia nigra and 17 in the locus coeruleus, per 1 mm2.
The density of TH-positive neurons in the substantia nigra
Fig. 7 Strong expression of a mitochondrial outer membrane protein (TOM20) on the surface of Lewy bodies (LBs) in PLA2G6-associated
neurodegeneration (PLAN). The left and the right images show the dorsal nuclei of the vagus in a patient with PLAN. The center image
shows the substantia nigra in a patient with Parkinson disease (PD). TOM20 20-kDa translocase of the outer mitochondrial membrane, SN
substantia nigra, LC locus coeruleus, nX the dorsal nuclei of vagus, PD Parkinson disease, PLAN PLA2G6-associated neurodegeneration, LBs Lewy
bodies, TOM20 (−) TOM20-negative, partially (+) partially TOM20-positive, completely (+) completely TOM20-positive, number of LBs * mean (SD)
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was low, but that in the locus coeruleus was similar to that
in the control brains, despite the prominent presence of
LBs (Fig. 5e, f ). The proportion of LB-bearing dopamin-
ergic neurons was 6/17 in the substantia nigra and 17/81
in the locus coeruleus, respectively. Thus, a high propor-
tion of LB-bearing neurons and preserved neuronal num-
ber were observed in PLAN.
Preserved expression of TH in dopaminergic neurons,
despite the presence of LBs
To determine if LB influences the micro-environment in
dopaminergic neurons, we estimated cytoplasmic TH ex-
pression of LB-bearing neurons. Both in PD and PLAN
brains, most of the cytoplasmic TH expression in LB
bearing neurons was preserved, both in substantia nigra
and locus coeruleus (Table 3). Some LB-bearing neurons
were TH-negative. No relationship between cytoplasmic
TH expression and LB presence was found.
Discussion and conclusions
In this study, we demonstrated elevated expression of
αSyn both in cultured cells and in mice with PLA2G6 de-
ficiency. Prominent accumulation of PαSyn in damaged
mitochondria was shown in Pla2g6-KO mice, which con-
stitute a model of PLA2G6-associated neurodegeneration
(PLAN). In PLAN neurons, small PαSyn-positive granules
and Lewy Bodies (LBs) were covered with mitochondrial
membrane component on the surface. These findings sug-
gest that αSyn/PαSyn associates with damaged mitochon-
dria in PLAN.
Strong expression of αSyn was evident in Pla2g6-Kd
neuroblastoma cells and KO mouse neurons, suggesting
that endogenous αSyn was induced in neurons due to
PLA2G6-deficiency. In Pla2g6-KO mice, surprisingly
high levels of PαSyn expression were observed in neu-
rons; this was never seen in the wild-type mice. PαSyn
was detected on the surface of tiny granules, which had
a staining pattern that was apparently different from that
of the toxic strains of αSyn, including fibrils and ribbons
[6, 33]. Immunohistochemical and ultra-microscopic
data suggest that PαSyn-positive and PAS-positive gran-
ules were abnormal mitochondria with degenerated inner
membranes in KO mice, but not lysosomes or endoplas-
mic reticulum, as has been shown previously [4, 45].
Injury of the inner mitochondrial membrane leads to
permeabilization of mitochondria [2, 32, 50]. In KO mice
from young, many neuronal mitochondria with degener-
ated inner membrane were present, but neither autopha-
gic degradation (mitophagy) nor ubiquitination of
mitochondria were observed. Mitochondrial membrane
permeabilization also induces apoptosis [32, 49]. More
than 8 months after the appearance of mitochondria
with degenerated inner membranes, due to PLA2G6
deficiency, neuronal loss was not significant in mice,
suggesting that apoptosis did not occur to neurons.
TOM20-positive granules were ubiquitin-negative in
neurons and ubiquitin-positive in spheroids, suggesting
ubiquitination of mitochondria occurs in degenerated
axons, but not in neurons.
In aged KO mice, PαSyn-positive granules became more
degenerated morphologically, but the PαSyn expression
Table 2 The dopaminergic neuron density and the proportion of Lewy body-bearing neurons
Area Density of dopaminergic neurons
Control PD PLAN
(n = 5) (n = 7) (n = 1)
Substantia nigra LB harbouring neuron 0 1 (1) 6
total neuron 84 (14) 13 (6) 17
Locus coeruleus LB harbouring neuron 0 1 (3) 17
total neuron 77 (13) 9 (10) 81
TH tyrosine hydroxylase, Density of TH (+) neurons mean (SD) per mm2, control non-neurodegenerative disease, PD Parkinson disease, PLAN PLA2G6-associated
neurodegeneration, LB Lewy body
Table 3 The expression of tyrosine hydroxylase in dopaminergic neurons bearing Lewy bodies (LBs)
SN LC
PD PLAN PD PLAN
(n = 7) (n = 1) (n = 7) (n = 1)
Number of LB bearing neurons with the variety
of tyrosine hydroxylase expression
TH (+) 3 (2)* 34 2 (4) 19
TH (−) 1 (1) 3 1 (1) 0
total number 3 (2) 37 3 (4) 19
LB Lewy body, SN substantia nigra, LC, locus coeruleus, TH tyrosine hydroxylase, TH (+) TH-positve neuron, TH (−) TH-negative neuron, Number of neurons
mean (SD)
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level was maintained. αSyn/PαSyn seems to have a strong
affinity for the mitochondrial membrane [37, 52]. How-
ever, considering the different localization of PαSyn and
ubiquitin in axons, PαSyn seems to disappear from mito-
chondria before mitochondrial ubiquitination, following
membrane permeabilization. The elevated expression of
αSyn/PαSyn in mitochondria may be related to membrane
stabilization [40].
In the substantia nigra of 26S proteasome depleted
mice, neurodegeneration is accompanied by neuronal in-
clusions similar to Pale bodies [30], the precursors of LB
[46]. The inclusions contain mainly abnormal mitochon-
dria [30], suggesting that Pale body or LB might be
associated with abnormal mitochondria with bad quality
control owing to dysfunction of ubiquitin proteasome sys-
































a Mit with degenerated inner membrane
Fig. 8 The hypothetical scheme of the process of Lewy body formation in PLA2G6-associated neurodegeneration (PLAN). a Normal mitochondrion.
b αSyn/PαSyn accumulates at the damaged mitochondrial membrane with PLA2G6 dysfunction. c High expression of αSyn/PαSyn stabilizes the
mitochondrial membrane. d Due to the high affinity of αSyn for damaged mitochondrial membranes, mitochondria loaded with αSyn/PαSyn are
clustered. e The cluster of the damaged mitochondria forms a small inclusion that contains toxic materials inside. f The small inclusion becomes large
to be a Lewy body (LB), which boundary is formed by αSyn/PαSyn and mitochondrial membrane components. g When the boundary, which is sufficiently
strong to sequester toxic materials inside, the LB-bearing neuron survives for a long time. h When this boundary breaks down, pro-apoptotic materials are
released into the neuron, leading to rapid neuronal death. The image of neurons double-stained with immunohistochemistry for PαSyn (in brown) and
tyrosine hydroxylase (in blue) is taken from the locus coeruleus of a patient with PLAN in (g), and a patient with PD in (h)
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PLAN [15, 31, 36]. Considering the severity of mitochon-
drial degeneration in Pla2g6-KO mice, the association of
Pale bodies or LBs with mitochondria would be strongly
expected in PLAN.
Our double immunohistochemical data in PLAN re-
vealed that the surface of PαSyn-positive small inclu-
sions were TOM20-positive and CCO-negative, which is
the same expression pattern of granules seen in Pla2g6-
KO mouse neurons. αSyn/PαSyn appears to have a
strong affinity for mitochondrial membrane components
both in Pla2g6-KO mice and in the PLAN case investi-
gated here. Moreover, the small inclusions appeared to
cluster into a large inclusion, possibly due to the strong
affinity of αSyn for the mitochondrial membrane.
LB extracts from PD brains have been reported to
trigger αSyn pathology and motor deficits in mice and
monkeys, which suggests that LBs contain neurotoxic
materials [35]. However, the presence of LBs in dopa-
minergic neurons was not associated with the low cyto-
plasmic expression of TH, either in the autopsied PLAN
or PD brains studied here, although this occurs early in
PD [21]. This suggests that the presence of LB would
not necessarily convey negative effects on the micro-
environment of neurons, in spite of the neurotoxic ma-
terials inside the LB.
A certain proportion of LB-bearing neurons is re-
ported to occur in the substantia nigra (3.6 % on
average), and this does not correlate with the symp-
toms or disease duration [14, 18]. In our case of
PLAN, a high proportion of dopaminergic neurons
harbor LBs, suggesting the long-term survival of these
neurons. In particular, the neurons were preserved
well in the locus coeruleus, despite the presence of
multiple LBs. This suggests that LBs in PLAN have a
low toxicity. As αSyn/PαSyn-loading mitochondria
with degenerated inner membrane did not lead to
neuronal death in mice, high concentrations of mito-
chondrial membrane components on the surface of
LBs may be associated with the low toxicity of LBs in
PLAN through the stabilization of the mitochondrial
lipid membrane [7, 29].
We illustrate this hypothesis in Fig. 8. Because of
PLA2G6 dysfunction, the mitochondrial inner mem-
brane is damaged early on. Strong affinity of αSyn/PαSyn
for damaged mitochondrial membrane induces Syn/
PαSyn to accumulate on the membrane. Elevated ex-
pression of αSyn/PαSyn stabilizes the mitochondrial
membrane and prevents membrane permeabilization.
The strong affinity of αSyn for damaged mitochondrial
membranes also causes clustering of the damaged
mitochondria to form LB. The outer structure, which is
comprised of a mitochondrial membrane component,
functions as a barrier and allows LB-bearing neurons to
survive for a long time. When the barrier breaks down,
pro-apoptotic materials, which are elevated in PLA2G6
deficiency [20], are released into the cytoplasm, followed
by rapid cell death.
In conclusion, αSyn/PαSyn accumulation in damaged
mitochondria of Pla2g6-KO mice and LBs in PLAN
indicates a common pathological mechanism, which in-
cludes the strong affinity of αSyn for damaged mito-
chondrial membranes. PLAN patients with late onset
tend to show prominent αSyn accumulation in neurons
[31]. Endogenous αSyn could be neuroprotective by sta-
bilizing mitochondrial membranes in neurodegenerative
diseases, such as PLAN and possibly even in PD, which
may indicate a new target for the treatment of α-
synucleinopathy.
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